In placebo-controlled trials, cholelithiasis was reported in 1.5% and 0.4% of patients treated with Ozempic injection 0.5 mg and 1 mg, respectively, and not reported in placebo-treated patients
Every recipe was built around a GLP-1 appetite first
Tinsley and Heymsfield - Body Composition and GLP-1 RA Treatments (Journal of the Endocrine Society, 2024)Supports: GLP-1-specific review of body-composition terminology, protein evidence, resistance exercise, and uncertainty around reference body weight
Investigated in rodent and non-human primate models of diet-induced obesity, hepatic steatosis and glycaemic dysregulation
Common and Rare Adverse Effects of GLP-1 Agonists While highly effective, GLP-1 receptor agonists can cause temporary side effects as your body adjusts to the metabolic changes
Because both medications affect digestion and appetite regulation, gastrointestinal symptoms are the most commonly reported side effects